Category: Biotechnology
The collaboration will conduct new synthetic control arm and potential RWD outcomes study designs for therapeutics that are based on both pre- and post-approval. Concerto HealthAI, a leading company …
The milestone payment comes as a part of the multi-target, multi-year collaboration between the two firms. The collaboration is one of many such partnerships Schrödinger has signed with global …
QUE Oncology has reportedly launched its Phase II trials at key locations in the United States, to test its new non-hormonal therapy Q-122, for female breast cancer patients suffering …
The Fast Track program of FDA has been designed to develop and expedite the review of drugs for the treatment of serious conditions and complete an unmet medical need. The …
The latest results indicate a promising risk-benefit profile in all pemphigus patients Principia Biopharma now intends to confirm these results through the current Phase 3 PEGASUS study Principia Biopharma …
CureVac’s vaccine platform has the potential to improve CEPI’s ability to respond to the emerging Disease X, claims CEPI CEO. In a move to defeat the next pandemic, the …
The Swiss biopharmaceutical company, CRISPR Therapeutics, and Durham-based leading developer of new AAV (adeno-associated viral)-based gene therapies, StrideBio Inc., have recently announced the extension of their development & option …
Debiopharm International to start Phase II clinical trial for evaluating Debio 1347 in advanced solid tumors Patients for the research will be enrolled in North America, South America, Europe, …
UK’s drug discovery biotechnology company focusing on immune-oncology, Grey Wolf Therapeutics, recently announced that it has completed a £10 million series A financing round with the leading investors in …
The collaboration will be funded by Sanofi and the research would be reportedly conducted at AbSci. As per the agreement, AbSci will apply SoluProTM – the company’s breakthrough E. …
